サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606471

バイオテクノロジー原料市場：タイプ別、発現システム別、用途別、地域別 - 2024～2032年の産業分析、市場規模、市場シェア、予測

Biotech Ingredients Market, By Type, By Expression System, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 284 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオテクノロジー原料市場：タイプ別、発現システム別、用途別、地域別 - 2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 284 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

バイオテクノロジー原料市場は2023年に21億5,150万米ドルに達し、2024年～2032年のCAGRは8.00%で拡大すると予測されます。

バイオテクノロジー原料市場 - 市場力学

ジェネリック医薬品へのニーズの高まり

ジェネリック医薬品へのニーズの高まりにより、バイオテクノロジー原料市場は今後も拡大すると予想されます。ジェネリック医薬品は、以前から認可されている医薬品と同じ品質を持つことを目的としています。一般医療がバイオ医薬品を使用するのは、バイオ医薬品が、より安価で、より効果的な方法で、先発品とほぼ同等の様々な有効成分を製造する主要な供給源であり、通常、より厳しい規制の対象となるからです。例えば、2022年9月、米国を拠点とするジェネリック医薬品製造・販売業者の団体であるAAM（Association for Accessible Medicines）の一部門であるバイオシミラー協議会が発表した「米国ジェネリック医薬品・バイオシミラー医薬品貯蓄レポート」によると、2021年に米国で患者に処方された64億件の処方箋のうち91％がジェネリック医薬品またはバイオシミラー医薬品であることが明らかになりました。ジェネリック医薬品は全ヘルスケア支出の3％を占めており、患者、消費者、雇用主、納税者は、これらの安価な医薬品を使用することで3,730億米ドルを節約することができます。このように、ジェネリック医薬品の需要増加により、バイオテクノロジー原料市場は拡大しています。

バイオテクノロジー原料市場 - 主要インサイト

調査アナリストの分析によると、世界市場は2024～2032年の予測期間中に約8.00%のCAGRで拡大すると予測されています。

タイプ別では、原薬カテゴリーが2023年に最大の市場シェアを占めると予測されました。

微生物発現システムカテゴリーは、発現システムに基づいて2023年に最大の市場シェアを占めると予測されました。

北米は2023年に地域別で最大の収益シェアを占めました。

バイオテクノロジー原料市場 - セグメンテーション分析：

世界のバイオテクノロジー原料市場は、タイプ、発現システム、用途、地域に区分されます。

バイオテクノロジー原料の世界市場は、タイプ別にバイオシミラーと原薬に分けられます。2023年、市場最大の貢献者は医薬品原薬カテゴリーです。医薬品有効成分（API）は、最終製品または最終製品に利用される化学物質または混合物質です。APIは、さまざまな疾患の治療に使用される薬剤の生体への影響を調べる薬理学研究での使用を目的としています。様々な診断、治療、予防、治療、緩和の目的に直接関係する原因や結果を調査する場合、原薬が使用されます。ほとんどの場合、製剤は最も熱力学的に安定な結晶形の原薬を使用します。原薬の品質は医薬品の有効性と安全性に強く影響します。

用途に基づき、市場はワクチン、モノクローナル抗体、サイトカイン、ホルモン・成長因子、融合タンパク質、血液因子、治療用酵素に区分されます。モノクローナル抗体は、その高い特異性、低毒性、特定の疾患マーカーを標的とする能力から、バイオテクノロジー原料の世界市場を独占すると予想されています。加えて、慢性疾患の罹患率の増加と個別化された治療オプションの需要が、市場拡大を後押しします。モノクローナル抗体（mAbs）として知られる合成タンパク質は、特定の細胞やタンパク質を標的とすることで、侵入者を撃退する免疫系の能力を再現します。これらのバイオテクノロジー成分は、がん、自己免疫疾患、感染症など多くの病気の治療に応用されているため、製薬業界で大きく成長しています。

バイオテクノロジー成分市場 - 地理的洞察

バイオテクノロジー原料市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカに広く分布しています。これらの地域は、ビジネスを提供する国によってさらに分けられています。

北米は製薬会社や食品会社が強く、バイオテクノロジーの研究開発に多額の投資を行っているため、バイオテクノロジー原料の市場は北米が独占しています。市場の拡大は、この地域の確立されたヘルスケアシステムと有利な規制環境に助けられています。食品・飲料、化粧品、医薬品におけるバイオテクノロジー原料の需要増加により、米国は市場に大きく貢献しています。バイオテクノロジーへの投資拡大と持続可能な製品に対する消費者の意識の高まりにより、カナダも急速な成長を遂げています。

さらに、多くの製薬会社や化粧品会社が存在し、持続可能な製品に対する消費者の需要が高まっていることから、欧州もバイオテクノロジー原料市場のかなりの部分を占めています。市場を牽引しているのはドイツ、フランス、英国で、いずれもバイオテクノロジーの研究開発に多額の資金を投じています。バイオテクノロジー物質の使用は、この地域の厳しい規制と環境の持続可能性の重視によって促進されています。さらに、ナチュラル＆オーガニック製品の人気の高まりが、欧州のバイオテクノロジー原料市場の拡大を後押ししています。

バイオテクノロジー原料市場 - 競合情勢：

バイオテクノロジー原料市場は、さまざまな産業で最先端のバイオテクノロジー・ソリューションに対する需要が拡大する中、多くの老舗企業と新規参入企業が市場シェアを争うダイナミックな競合環境が特徴です。AbbVie Inc.、Pfizer Inc.、Boehringer Ingelheim International GmbH、Lilly、GSK Plc、Novartis AGなどの重要企業は、技術改善、持続可能なビジネス慣行、規制遵守を重視し、製品ラインを拡大するための研究開発プロジェクトに常に取り組んでいます。変化する顧客の需要に応え、市場での競争力を維持するため、業界各社は戦略的提携、合併、買収を通じて、世界中に手を広げ、さまざまなバイオ医薬品原料を提供しようとしています。

目次

第1章 バイオテクノロジー原料市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 バイオテクノロジー原料の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 バイオテクノロジー原料産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 バイオテクノロジー原料市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 バイオテクノロジー原料市場情勢

  • バイオテクノロジー原料市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 バイオテクノロジー原料市場：タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • バイオシミラー
    • 医薬品有効成分

第8章 バイオテクノロジー原料市場：発現システム別

  • 概要
    • 発現システム別セグメントシェア分析
    • 植物発現システム
    • 哺乳類発現システム
    • 酵母発現システム
    • 微生物発現システム
    • 昆虫発現システム

第9章 バイオテクノロジー原料市場：用途別

  • 概要
    • 用途別セグメントシェア分析
    • ワクチン
    • モノクローナル抗体
    • サイトカイン
    • ホルモンと成長因子
    • 融合タンパク質
    • 血液因子
    • 治療用酵素

第10章 バイオテクノロジー原料市場：地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析 - バイオテクノロジー原料業界

  • 競合ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.（US）
    • Pfizer Inc.（US）
    • Boehringer Ingelheim International GmbH.（Germany）
    • Lilly（US）
    • GSK Plc（UK）
    • Novartis AG（Switzerland）
    • Bristol-Myers Squibb Company（US）
    • Merck &Co（US）.
    • Sanofi（France）
    • bioMerieux（France）
    • Cepheid Inc.（US）
    • AstraZeneca（UK）
    • Mylan NV（US）
    • BD（US）
    • Teva Pharmaceutical Industries Ltd.（Israel）
    • Bruker（US）
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4267

REPORT HIGHLIGHT

The market for Biotech Ingredients was projected to reach USD 2,151.5 million in 2023 and expand at a CAGR of 8.00% between 2024 - 2032.

The majority of biotech ingredients are natural and include oleoresins, essential oils, and other plant extracts. Common methods for obtaining these compounds include carbon dioxide extraction, solvent extraction, steam distillation, and cold pressing or compression. Biotech ingredients, like biopharmaceuticals, include complex proteins, such antibodies, nucleic acids, or antisense oligonucleotides, which are given by methods different from direct extraction from natural, non-engineered living forms. Due to reasons including consumers' growing preference for natural and organic products, the market for biotech ingredients has grown significantly. Additionally, this market is being driven by the growing usage of biotech components in various end-use industries, including medicines, cosmetics, and food & beverage. In addition, technological developments pertaining to monoclonal antibodies and next-generation antibody therapeutics, including antibody-drug conjugates by major companies, are some other aspects anticipated to further influence the biotech ingredients market.

Biotech Ingredients Market- Market Dynamics

Rising Need for Generic Medications

It is anticipated that the market for biotech ingredients will continue to expand due to the growing need for generic medications. A generic medication is intended to have the same qualities as a previously authorized medication. General medicine uses biotech substances because they are the main source of less expensive, more effective ways to produce a variety of active ingredients that are almost comparable to the original product and are usually subject to a more stringent set of regulations. For instance, in September 2022, the U.S. Generic and Biosimilar Medicines Savings Report, published by the Biosimilars Council, a division of the Association for Accessible Medicines (AAM), a US-based association of generic medicine manufacturers and distributors, revealed that 91% of the 6.4 billion prescriptions were written for patients in the US in 2021 for generic or biosimilar medications. With generic medications accounting for 3% of all healthcare spending, patients, consumers, employers, and taxpayers saved $373 billion by using these less expensive medications. Thus, the market for biotech ingredients is expanding due to the increased demand for generic medications.

Biotech Ingredients Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 8.00% during the forecast period of 2024-2032.

The active pharmaceutical ingredients category was predicted to hold the largest market share in 2023 based on type.

The microbial expression systems category was predicted to hold the largest market share in 2023 based on expression systems.

North America held the largest revenue share by region in 2023.

Biotech Ingredients Market- Segmentation Analysis:

The Global Biotech Ingredients Market is segmented into Type, Expression System, Application, and Region.

The global market for biotech ingredients is divided into two segments based on type: biosimilars and active pharmaceutical ingredients. In 2023, the market's largest contributor is the active pharmaceutical ingredients category. Active pharmaceutical ingredients (APIs) are the chemicals or a mixture of substances utilized in final or finished products. They are intended for use in pharmacology studies to investigate the effects of drugs on living organisms when they are used to treat different diseases. When researching causes and consequences that are directly related to different diagnoses, cures, preventive, therapy, and mitigation aims, APIs are used. In most cases, a formulation uses the most thermodynamically stable crystalline form of API. The quality of APIs strongly impacts the efficacy and safety of pharmaceuticals.

Based on application, the market is segmented into Vaccines, Monoclonal Antibodies, Cytokines, Hormones and Growth Factors, Fusion Proteins, Blood Factors, and Therapeutic Enzymes. Due to its high specificity, low toxicity, and capacity to target particular disease markers, monoclonal antibodies are expected to dominate the global market for biotech ingredients. Additionally, the growing incidence of chronic illnesses and the demand for individualized treatment options will propel market expansion. Synthetic proteins known as monoclonal antibodies (mAbs) replicate the immune system's ability to fight off intruders by targeting particular cells or proteins. These biotech components have grown significantly in the pharmaceutical industry because of their therapeutic applications in the treatment of many illnesses, including cancer, autoimmune diseases, and infectious diseases.

Biotech Ingredients Market- Geographical Insights

The Biotech Ingredients market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

The market for biotech ingredients is dominated by North America, mostly because of the region's strong pharmaceutical and food companies as well as its substantial investments in biotechnology R&D. The market's expansion is being aided by the region's established healthcare system and advantageous regulatory environment. Due to the increasing demand for biotech ingredients in food and drink, cosmetics, and pharmaceuticals, the US is a significant contributor to the market. With the help of growing biotechnology investments and growing consumer awareness of sustainable products, Canada is also experiencing rapid growth.

Additionally, with the help of a large number of pharmaceutical and cosmetic firms as well as rising consumer demand for sustainable products, Europe also commands a sizable portion of the market for biotech ingredients. The market is mostly driven by Germany, France, and the United Kingdom, all of which have made large expenditures in biotechnology R&D. The use of biotech substances is being fueled by the region's strict regulations and emphasis on environmental sustainability. Furthermore, the growing popularity of natural & organic products is driving the European biotech ingredients market's expansion.

Biotech Ingredients Market- Competitive Landscape:

The market for biotech ingredients is characterized by a dynamic competitive environment with many well-established companies and newcomers vying for market share in the expanding demand for cutting-edge biotechnology solutions across a range of industries. Important companies such as AbbVie Inc., Pfizer Inc., Boehringer Ingelheim International GmbH, Lilly, GSK Plc, Novartis AG, and others always work on R&D projects to expand their product lines, emphasizing technological improvements, sustainable business practices, and regulatory compliance. In order to meet changing customer demands and maintain a competitive edge in the market, industry players are attempting to broaden their worldwide reach and provide a variety of biotech ingredients through strategic alliances, mergers, and acquisitions.

Recent Developments:

May 2023: The renowned biotech company Willow Biosciences Inc., which aims to revolutionize the industrial production of sustainable and pure functional components, has inked a Master Services Agreement with a cutting-edge biotech company that focuses on age-related illnesses. In this partnership, it will develop precise fermentation processes for a particular class of molecules created as active pharmaceutical ingredients (APIs) and nutritional supplements for health and wellness.

February 2023: CETO3 is an omega-3 and cetoleic acid that Grntvedt Biotech introduced. It has been investigated if cetoleic acid, sometimes referred to as "omega 11," can change alpha-lipoic acid (ALA), a plant-based omega-3 fatty acid, into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells. It's a chemical from Norwegian herring that's being used for skin and heart health.

February 2022: For $226 million, the Irish taste and nutrition giant Kerry Group plc purchased c-LEcta. Kerry hopes to enhance its innovation efforts in fermentation, enzyme engineering, and biotechnological development with this acquisition. Kerry also intends to make investments in the development of innovative sustainable technologies that will propel the future growth of sustainable food and health systems. c-LEcta is a biotechnology innovation company based in Germany that specializes in producing high-value targeted biomolecules and ingredients through extremely accurate fermentation, optimized bio-processing, and bio-transformation.

SCOPE OF THE REPORT

The scope of this report covers the Biotech Ingredients market by its major segments, which include as follows:

GLOBAL BIOTECH INGREDIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Boehringer Ingelheim International GmbH. (Germany)
  • Lilly (U.S.)
  • GSK Plc (U.K.)
  • Novartis AG (Switzerland)
  • Bristol-Myers Squibb Company (U.S.)
  • Merck & Co (U.S.).
  • Sanofi (France)
  • bioMerieux (France)
  • Cepheid Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Mylan N.V (U.S.)
  • BD (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bruker (U.S.)
  • Others

GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biosimilars
  • Active Pharmaceutical Ingredients

GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEM- MARKET ANALYSIS, 2019 - 2032

  • Plant Expression Systems
  • Mammalian Expression Systems
  • Yeast Expression Systems
  • Microbial Expression Systems
  • Insect Expression Systems

GLOBAL BIOTECH INGREDIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Vaccines
  • Monoclonal Antibodies
  • Cytokines
  • Hormones and Growth Factors
  • Fusion Proteins
  • Blood Factors
  • Therapeutic Enzymes

GLOBAL BIOTECH INGREDIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biotech Ingredients Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biotech Ingredients Market Snippet by Type
    • 2.1.2. Biotech Ingredients Market Snippet by Expression System
    • 2.1.3. Biotech Ingredients Market Snippet by Application
    • 2.1.4. Biotech Ingredients Market Snippet by Country
    • 2.1.5. Biotech Ingredients Market Snippet by Region
  • 2.2. Competitive Insights

3. Biotech Ingredients Key Market Trends

  • 3.1. Biotech Ingredients Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biotech Ingredients Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biotech Ingredients Market Opportunities
  • 3.4. Biotech Ingredients Market Future Trends

4. Biotech Ingredients Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biotech Ingredients Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biotech Ingredients Market Landscape

  • 6.1. Biotech Ingredients Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biotech Ingredients Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Biosimilars
    • 7.1.3. Active Pharmaceutical Ingredients

8. Biotech Ingredients Market - By Expression System

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Expression System, 2023 & 2032 (%)
    • 8.1.2. Plant Expression Systems
    • 8.1.3. Mammalian Expression Systems
    • 8.1.4. Yeast Expression Systems
    • 8.1.5. Microbial Expression Systems
    • 8.1.6. Insect Expression Systems

9. Biotech Ingredients Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Vaccines
    • 9.1.3. Monoclonal Antibodies
    • 9.1.4. Cytokines
    • 9.1.5. Hormones and Growth Factors
    • 9.1.6. Fusion Proteins
    • 9.1.7. Blood Factors
    • 9.1.8. Therapeutic Enzymes

10. Biotech Ingredients Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biotech Ingredients Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biotech Ingredients Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biotech Ingredients Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Biotech Ingredients Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Biotech Ingredients Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biotech Ingredients Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc. (U.S.)
    • 11.2.2. Pfizer Inc. (U.S.)
    • 11.2.3. Boehringer Ingelheim International GmbH. (Germany)
    • 11.2.4. Lilly (U.S.)
    • 11.2.5. GSK Plc (U.K.)
    • 11.2.6. Novartis AG (Switzerland)
    • 11.2.7. Bristol-Myers Squibb Company (U.S.)
    • 11.2.8. Merck & Co (U.S.).
    • 11.2.9. Sanofi (France)
    • 11.2.10. bioMerieux (France)
    • 11.2.11. Cepheid Inc. (U.S.)
    • 11.2.12. AstraZeneca (U.K.)
    • 11.2.13. Mylan N.V (U.S.)
    • 11.2.14. BD (U.S.)
    • 11.2.15. Teva Pharmaceutical Industries Ltd. (Israel)
    • 11.2.16. Bruker (U.S.)
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us